首页> 外文期刊>Nature reviews. Urology >The translational potential of microRNAs as biofluid markers of urological tumours
【24h】

The translational potential of microRNAs as biofluid markers of urological tumours

机译:microRNAs作为泌尿外科肿瘤生物流体标记物的翻译潜力

获取原文
获取原文并翻译 | 示例
           

摘要

MicroRNAs (miRNAs) are secreted by cells in-vesicles, bound in a ribonucleoprotein complex or as free molecules. These miRNA secretion pathways are dysregulated in cancer, making miRNAs attractive candidate molecules for liquid biopsies. A number of studies have investigated the regulation of miRNA secretion into blood and urine and suggested that miRNAs are noninvasive diagnostic, prognostic and surveillance markers in urological carcinomas, and research in this area has increased over the past 5 years. However, methodological and analytical pitfalls exist and require addressing to enable future translation of the laboratory findings regarding miRNAs as biomarkers into clinical practice in bladder cancer, kidney cancer, prostate cancer and testicular cancer.
机译:MicroRNA(miRNA)由细胞囊泡分泌,结合在核糖核蛋白复合物中或作为游离分子。这些miRNA分泌途径在癌症中失调,使miRNA成为液体活检的有吸引力的候选分子。许多研究已经调查了miRNA分泌到血液和尿液中的调控,并暗示miRNA是泌尿科癌的非侵入性诊断,预后和监视标志物,并且在过去5年中对该领域的研究有所增加。但是,存在方法上和分析上的陷阱,需要解决这些问题,以使将来将miRNA作为生物标志物的实验室发现转化为膀胱癌,肾癌,前列腺癌和睾丸癌的临床实践。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号